Inmune Bio share price logo

Inmune Bio

NASDAQ: INMB

$2.35

Live

as on

Inmune Bio Stock Performance

as on September 4, 2026 at 2:10 am IST

  • Day's Low

    Day's High

    $2.31
    $2.41
    downward going graph

    1.70%

    Downside

    2.55%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.09
    $2.50
    downward going graph

    53.62%

    Downside

    6.34%

    Upside

    downward going graph

Inmune Bio share price movements today

Previous Close
$2.35
Open
$2.38
Volume
167.2K
Market Cap
$62.2M
Day's Low - High
$2.31 - $2.41
52 Week Low - High
$1.09 - $2.50

Inmune Bio Historical Returns

1 Month Return
+ 28 %
3 Month Return
+ 57.75 %
1 Year Return
+ 13.71 %
3 Year Return
-73.19 %
5 Year Return
-90.67 %

Inmune Bio Stock Fundamentals & Key Indicators

Check Inmune Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$62.2M

EPS (TTM)

-0.69

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.01

Industry PE ratio

-1.4626335877862595

PEG Ratio

-0.02428652212259218

EBITDA

-18.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-82.87%

Inmune Bio Stock Valuation

Track how Inmune Bio P/E has moved over time to understand its valuation trends.

Inmune Bio in the last 5 years

  • Overview

  • Trends

Lowest (-6.75x)

December 31, 2023

Industry (-1.46x)

December 31, 2025

Today (-0.84x)

December 31, 2025

Highest (-0.84x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.84x

Inmune Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Inmune Bio with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$62.2M-90.67%-3.010.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for Inmune Bio Stock including INR - Dollar returns

The Inmune Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Inmune Bio investment value today

Current value as on today

₹1,27,960

Returns

₹27,960

(+27.96%)

Returns from Inmune Bio Stock

₹19,289 (+19.29%)

Dollar Impact

₹8,671 (+8.67%)

Analyst Recommendation on Inmune Bio Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Inmune Bio. Average target price of $7

Inmune Bio Share Price Target

Get share price movements and forecasts by analysts on Inmune Bio.

What analysts predicted

66.43%UPSIDE

Target Price

$7

Current Price

$2.35

Analyzed by

1 Analysts

Target

$7.00

Inmune Bio target price $7, a slight upside of 66.43% compared to current price of $2.35. According to 1 analysts rating.

Indian Investors' Interest in Inmune Bio Stock

Search interest for Inmune Bio Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Inmune Bio Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
-
-
-
0
-
-
-
-
-
Gross Profit
0
-
-
-
0
-
-
0
0
-
Operating Income
-11
-9
-12
-9
-9
-24
-7
-5
-5
-1
EBITDA
-10
0
-12
-9
-9
-8
-6
-5
-5
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
9
-
-
-
-
-
0
0
0
Income Before Tax
-11
-9
-12
-9
-9
-24
-6
-5
-5
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-11
-9
-12
-9
-9
-24
-6
-5
-5
-1
Net Profit Margin
100.00%
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Inmune Bio Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
0
0
0
0
0
0
Gross Profit
-
-
-
0
0
0
0
0
0
Operating Income
0
-12
-7
-12
-29
-25
-29
-42
-30
EBITDA
0
-
-7
-
-1
-1
0
-41
-45
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
12
-
12
29
25
29
0
0
Income Before Tax
0
-12
-7
-12
-30
-27
-30
-42
-45
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
0
-12
-7
-12
-30
-27
-30
-42
-45
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Inmune Bio Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-9
-12
-9
-9
-24
-6
40
-5
-1
Operating Cash Flow
-7
-7
-6
-11
-6
-7
-5
-2
-3
-3
Investing Cash Flow
-
-
-
-
-
0
0
0
-
0
Financing Cash Flow
-2
12
9
-2
5
22
-
0
-
0
Change in Cash
-9
5
2
-12
-1
14
-5
-2
-3
-2

Inmune Bio Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-12
-7
-12
-30
-27
-30
-42
-45
Operating Cash Flow
0
-2
-5
-8
-28
-22
-11
-33
-22
Investing Cash Flow
0
-
-
-
-15
-
-
-
-1
Financing Cash Flow
2
0
12
23
96
0
-4
18
27
Change in Cash
1
-1
6
14
52
-22
-16
-14
3

Mutual Funds that own Inmune Bio Stock

Check out the Mutual Funds with significant holdings in Inmune Bio.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.475391%
687015
Fidelity Salem Street Trust
0.823898%
228663
Fidelity Concord Street Trust
0.603247%
167424
VANGUARD SCOTTSDALE FUNDS
0.428647%
118966
SCHWAB CAPITAL TRUST
0.181063%
50252

Global Institutional Holdings in Inmune Bio

Funds
Holdings
Vanguard
2.47%
iShares
0.3%

Insights on Inmune Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, INMB stock has moved up by 27.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 14.0K → 50.0K (in $), with an average increase of 72.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -5.40M → -1.27M (in $), with an average increase of 324.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 507.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 34.0% return, outperforming this stock by 105.9%

About Inmune Bio

INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. The company's development programs include INKmune, which is in Phase 1 for the treatment of patients with high-risk myelodysplastic syndrome; and INB03, which is in Phase II for the treatment of breast cancer. It provides XPro1595 for the treatment of Alzheimer's disease and treatment resistant depression; and CORDstrom, a cell suspension for intravenous infusion or injection comprising aseptic, allogeneic, and pooled HucMSCs. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; GOSH; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.
OrganisationInmune Bio
Headquarters225 NE Mizner Blvd., Boca Raton, FL, United States, 33432
IndustryBiotechnology
CEOMr. David J. Moss M.B.A.
E-voting on sharesClick here to vote

Key Management of Inmune Bio

Name

Title

Mr. Cory Randall Ellspermann

Interim Chief Financial Officer

Dr. Mark William Lowdell Ph.D.

Co-Founder, Chair of Scientific Advisory Board, CSO & Chief Manufacturing Officer

Mr. Daniel Frederick Carlson

Head of Investor Relations

Mr. Joshua S. Schoonover Esq.

General Counsel

Mr. David J. Moss M.B.A.

President, CEO, Treasurer, Secretary & Director

FAQs

What is Inmune Bio share price today?

Inmune Bio share price today is $2.35 as on . Inmune Bio share today touched a day high of $2.41 and a low of $2.31.

What is the 52 week high and 52 week low for Inmune Bio share?

Inmune Bio share touched a 52 week high of $2.50 on and a 52 week low of $1.09 on . Inmune Bio stock price today i.e. is trending at $2.35,which is 5.96% down from its 52 week high and 115.60% up from its 52 week low.

What is Inmune Bio's market capitalisation today?

Inmune Bio market capitalisation is $0.00T as on .

How to invest in Inmune Bio Stock (INMB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inmune Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inmune Bio Shares that will get you 0.6383 shares as per Inmune Bio share price of $2.35 per share as on September 3, 2026 at 8:40 pm IST.

What is the minimum amount required to buy Inmune Bio Stock (INMB) from India?

Indian investors can start investing in Inmune Bio (INMB) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Inmune Bio stock (as per the Rupee-Dollar exchange rate as on ). Based on Inmune Bio share’s latest price of $2.35 as on September 3, 2026 at 8:40 pm IST, you will get 4.2553 shares of Inmune Bio. Learn more about fractional shares .

What are the returns that Inmune Bio has given to Indian investors in the last 5 years?

Inmune Bio stock has given -90.67% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?